Detalhe da pesquisa
1.
Identification of new candidate biomarkers to support doxorubicin treatments in canine cancer patients.
BMC Vet Res
; 17(1): 378, 2021 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34876121
2.
Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma.
BMC Vet Res
; 14(1): 250, 2018 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30143046
3.
Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma.
Vet Sci
; 10(4)2023 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104404
4.
Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses.
Mol Ther Oncolytics
; 29: 129-142, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37313455
5.
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma.
bioRxiv
; 2023 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131624
6.
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma.
Mol Ther Oncolytics
; 31: 100736, 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965295
7.
Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells.
Front Immunol
; 13: 841859, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35281028
8.
Clinical validation of a next-generation sequencing-based multi-cancer early detection "liquid biopsy" blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study.
PLoS One
; 17(4): e0266623, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35471999
9.
Retrospective evaluation of thrombocytopenia and tumor stage as prognostic indicators in dogs with splenic hemangiosarcoma.
J Am Vet Med Assoc
; 258(6): 630-637, 2021 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33683962
10.
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs.
Clin Cancer Res
; 27(11): 3005-3016, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753454
11.
Emerging therapeutic approaches for canine sarcomas: Pushing the boundaries beyond the conventional.
Vet Comp Oncol
; 18(1): 9-24, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31749286
12.
Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma.
Vet Comp Oncol
; 18(4): 664-674, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32187827
13.
Use of computed tomography and radiation therapy planning software to develop a novel formula for body surface area calculation in dogs.
J Vet Intern Med
; 33(2): 792-799, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30835925
14.
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin.
Clin Pharmacol
; 10: 113-121, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30288129
15.
Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors.
Oncotarget
; 9(15): 11938-11947, 2018 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29552283
16.
Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
PLoS One
; 12(2): e0172651, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28222142
17.
Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.
Mol Cancer Ther
; 16(5): 956-965, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28193671
18.
A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma.
Vet Med Sci
; 2(3): 179-190, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29067193
19.
A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer Model.
PLoS One
; 11(2): e0149194, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26866698
20.
Clinical Signs, Treatment, and Outcome in Cats with Myeloma-Related Disorder Receiving Systemic Therapy.
J Am Anim Hosp Assoc
; 51(4): 239-48, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26083436